Cancer Cell Membrane-Coated NPs as a Biomimetic Strategy for Precision Tumor Therapy
Open Access
- 11 October 2025
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (10) , 1322
Abstract
Cancer treatment remains challenging due to the complexity of the tumor microenvironment, which promotes tumor heterogeneity and contributes to the development of multidrug resistance, ultimately hindering drug delivery and reducing therapeutic efficacy. In recent years, biomimetic nanocarriers have emerged as promising tools to address these challenges. Among them, cancer cell membrane (CCM)-coated nanoparticles (CCM-NPs) have attracted increasing attention due to their unique advantages, including homologous targeting, prolonged circulation mediated by self-recognition, and enhanced tumor penetration. Moreover, CCM-NPs can serve as versatile platforms for tumor vaccines by leveraging their inherent tumor-associated antigens and immunomodulatory potential. By leveraging CCMs to functionalize NPs, researchers have developed innovative approaches to improve drug delivery, enhance tumor immunotherapy, and optimize cancer vaccine efficacy. Despite these advancements, a comprehensive review summarizing the latest progress in CCM-based biomimetic nanocarriers for tumor treatment is lacking. This review integrates recent advances in CCM-NPs for targeted drug delivery and cancer vaccination, and discusses their fabrication, characterization, mechanisms and applications across multiple cancer types, which provides timely insights to guide their future development in precision tumor therapy.Keywords
Funding Information
- National Institute of Health (R01CA287091)
- FPBCC Cancer Center Support (CA036727)
This publication has 102 references indexed in Scilit:
- Biomimetic Tumor Cell Membrane‐Encapsulated Nanoparticles Combine NIR‐II Photothermal Therapy and Chemotherapy for Enhanced Immunotherapy in Triple‐Negative Breast CancerAdvanced Functional Materials, 2024
- Leveraging Senescent Cancer Cell Membrane to Potentiate Cancer Immunotherapy Through Biomimetic NanovaccineAdvanced Science, 2024
- Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapyExploration, 2024
- Improved Photodynamic Therapy Based on Glutaminase Blockage via Tumor Membrane Coated CB‐839/IR‐780 NanoparticlesSmall, 2023
- PEGylated therapeutics in the clinicBioengineering & Translational Medicine, 2023
- Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050JAMA Oncology, 2023
- Cell Membranes from Tumor‐Tropic MSCs Screened by a Microfluidic Chip for Drug Nanoparticles Encapsulation and Cancer Targeted TherapyAdvanced Healthcare Materials, 2023
- Correct Identification of the Core‐Shell Structure of Cell Membrane‐Coated Polymeric NanoparticlesChemistry – A European Journal, 2022
- The ever‐increasing importance of cancer as a leading cause of premature death worldwideCancer, 2021
- Cell Membrane Coating NanotechnologyAdvanced Materials, 2018